Market Overview

AnaptysBio (NASDAQ: ANAB)

11.68 +0.49 (4.38%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2020
Pre-Market
EPS:
REV:
-1.15
0



Q2 2020
After-Hours
EPS:
REV:
-0.89
5M



Q1 2020
After-Hours
EPS:
REV:
-0.82
0



Q4 2019
Pre-Market
EPS:
REV:
-0.64



Q3 2019
Pre-Market
EPS:
REV:
-0.66
5M

-1.15
0

Q2 2019
After-Hours
EPS:
REV:
-0.57
0
-0.99
-0.89
5M
10.1%
Q1 2019
After-Hours
EPS:
REV:
-0.63
0
-0.83
-0.82
0
1.2%
Q4 2018
Pre-Market
EPS:
REV:
-0.30
3M
-0.92
1.31M
-0.64
0
-30.43%
-100%
Q3 2018
After-Hours
EPS:
REV:
-0.45
-0.71
250K
-0.66
5M
-7.04%
1900%
Q2 2018
Pre-Market
EPS:
REV:
-0.01
18.285M

-0.57

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!